Evidence map›Paper›PMID 39588131›Full record

ArticleJBMR plus2024

Hip geometry and strength remain stable the first year after kidney transplantation-an ibandronate/placebo

Ruth C Strømmen, Kristin Godang, Markus H Hovd, Trine E Finnes, Knut Smerud, Anders Hartmann, Anders Åsberg, Jens Bollerslev, Hege K Pihlstrøm

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JBMR plus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruth C StrømmenSection of Nephrology, Department of Transplant Medicine, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.ORCID https://orcid.org/0009-0002-3840-3641
Kristin GodangSection of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.
Markus H HovdSection of Nephrology, Department of Transplant Medicine, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.ORCID https://orcid.org/0000-0002-6077-0934
Trine E FinnesSection of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.ORCID https://orcid.org/0000-0003-1102-8706
Knut SmerudSmerud Medical Research International AS, N-0212, Oslo, Norway.
Anders HartmannSection of Nephrology, Department of Transplant Medicine, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.
Anders ÅsbergSection of Nephrology, Department of Transplant Medicine, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.
Jens BollerslevFaculty of Medicine, University of Oslo, N-0316, Oslo, Norway.
Hege K PihlstrømSection of Nephrology, Department of Transplant Medicine, Oslo University Hospital, Rikshospitalet, N-0424, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sensitivity of bone mineral density (BMD) to identify patients with high fracture risk after kidney transplantation is low, therefore alternative tools are needed. Hip Structure Analysis (HSA) provides an estimation of hip structural geometry and strength based on conventional DXA scans for hip analyses. We aimed to investigate the effect of antiresorptive therapy on hip geometrical and strength parameters by HSA. In a

Indexed as

bisphosphonatecortical boneDXAhip structure analysiskidney transplantation

Identifiers

PMID39588131
PMCPMC11586456

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.